Literature DB >> 19221369

Evaluating off-label uses of anticancer drugs: time for a change.

Harold C Sox.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19221369     DOI： 10.7326/0003-4819-150-5-200903030-00110

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

Review 1.  [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Authors:  R W C Janzen; W D Ludwig
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

Review 2.  The National Drug Abuse Treatment Clinical Trials Network: forging a partnership between research knowledge and community practice.

Authors:  Betty Tai; Steven Sparenborg; David Liu; Michele Straus
Journal:  Subst Abuse Rehabil       Date:  2011-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.